Immediate Impact
3 from Science/Nature 64 standout
Citing Papers
Lipoprotein(a) and cardiovascular disease
2024 Standout
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Works of M. Vergeer being referenced
C-reactive protein is a mediator of cardiovascular disease
2010
Combination statin–fibrate therapy: safety aspects
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| M. Vergeer | 175 | 18 | 80 | 109 | 96 | 12 | 517 | |
| Thomas Julian | 51 | 1 | 224 | 46 | 95 | 25 | 598 | |
| Thijs van Iersel | 180 | 19 | 90 | 53 | 16 | 592 | ||
| S. Vallgren | 236 | 18 | 21 | 36 | 158 | 22 | 576 | |
| Jingting Wu | 72 | 188 | 34 | 66 | 16 | 497 | ||
| Praful Kelkar | 63 | 2 | 277 | 38 | 57 | 24 | 502 | |
| Aline C. Oliveira | 43 | 6 | 31 | 50 | 174 | 20 | 498 | |
| Yen‐Chieh Lee | 122 | 14 | 139 | 32 | 60 | 16 | 522 | |
| Ulla Bjerre | 161 | 20 | 101 | 150 | 80 | 8 | 608 | |
| Ralph E. Watson | 140 | 6 | 14 | 27 | 112 | 14 | 467 | |
| Göran Sandén | 198 | 10 | 83 | 122 | 114 | 9 | 586 |
All Works
Login with ORCID to disown or claim papers
Loading papers...